Loading...
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
BACKGROUND: The US Food and Drug Administration authorized COVID-19 convalescent plasma (CCP) therapy for hospitalized COVID-19 patients via the Expanded Access Program (EAP) and the Emergency Use Authorization (EUA), leading to use in about 500,000 patients during the first year of the pandemic for...
Na minha lista:
| Udgivet i: | eLife |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
eLife Sciences Publications, Ltd
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8205484/ https://ncbi.nlm.nih.gov/pubmed/34085928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7554/eLife.69866 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|